Funding
Series B · Healthtech

Fize Medical completes first close toward $20m Series B target

Asahi Kasei Medical and Rapha Capital Management led the undisclosed first tranche.

Updated Oct 16, 2026By RoundOS Funding desk

The company says the first close is part of a $20 million Series B target; the amount raised in this tranche was not disclosed. Fize plans to advance Optima and strengthen commercial activity in markets where its systems are available.

Use of funds

Accelerate development of Fize Optima for AI-driven prediction and treatment guidance

Strengthen commercial activities in leading markets

Funding history

Series B · This roundUndisclosed

Sources

  1. Fize Medical Raises The First Close Of Its Series B Fundingfinsmes.com · Sep 18, 2026
  2. fizemedical.com
  3. fizemedical.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026

Related